Laddar populära aktier...
Scandinavian Astor Group (”Astor Group” eller ”bolaget”) meddelade den 9 april att bolaget har ingåt...
Redeye briefly comments on Lytix’ share issue. We pause our coverage.
Redeye leaves an initial comment following the Q2 report published by Newbury this morning.
Redeye comments on the outcome in the rights issue, with a subscription rate of 71%.
Scanfil's valuation is 20% below the peer group median, but a small discount may be justified as lon...
Order intake likely to improve Sports & outdoor demand should normalise during '24 '24e-'26e EBIT up...
Redeye leaves a comment following Faron’s announcement of a change in its CEO position.
Redeye views the news from Moberg Pharma that they have submitted an additional Terbinafine supplier...
Redeye provides preview on SSH Communications Security Q1 results scheduled for release on April 24.
Redeye has provided a brief comment on today's news regarding Acarix's submission of an application ...
Redeye comments on today’s news. Scibase has resolved a directed issue of c SEK 33m and a rights iss...
Pharma Equity Group (“PEG” or “the Company”) announced on Friday, April 5th, that the Company’s subs...
Har ni glömt bort SinterCast? Traton och Volvo har rusat på börsen.
Mendus has reported gross proceeds of c SEK69.1m from the exercise of series TO3 warrants that were ...
Redeye leaves a comment following Faron’s announcement of a conducted private placement raising EUR4...